340 filings
Page 3 of 17
6-K
q6i9fy9vibw
7 Nov 22
Kamada Provides Update on Recent Progress Achieved in Ongoing Pivotal Phase 3 Clinical Trial of Inhaled AAT
7:00am
6-K
asgn1pa sq
26 Oct 22
Kamada to Present at the Credit Suisse 31st Annual Healthcare Conference
7:00am
6-K
c2pr5fl5hjuzlc lrwir
19 Oct 22
Kamada Awarded $22 Million Extension of Canadian Supply Tender
7:00am
6-K
4upu5ati309rr
17 Aug 22
Report of Foreign Private Issuer
7:00am
6-K
emy4pj8r
10 Aug 22
Report of Foreign Private Issuer
12:00am
6-K
lou3ayd
15 Jul 22
Kamada Announces Resolution the Labor Strike at the Company’s Manufacturing Facility in Israel; A New, Eight-Year Collective Agreement Signed
7:04am
6-K
9u3pekmio8kt2582
6 Jul 22
Kamada Announces $11.4 Million International VARIZIG® Procurement Agreement
6:01am
S-8
nh90bg2uje q0bcf
28 Jun 22
Registration of securities for employees
8:33am
6-K
1cj7yr3ink 98
15 Jun 22
Report of Foreign Private Issuer
7:00am
6-K
dev0imou1i
1 Jun 22
Kamada to Host a Virtual Analysts and Investors Meeting to Review its Growth Catalysts
7:02am
6-K
cft6k37d80ub mn99wij
17 May 22
Reiterates Revenue and Profitability Guidance with Significant Growth Expected in 2022
7:05am
6-K
t2c 8g1znrow8
17 May 22
Report of Foreign Private Issuer
7:00am
6-K
tgzgsumyskl
11 May 22
Report of Foreign Private Issuer
7:00am
6-K
puva5 8p12g2a59s
26 Apr 22
Report of Foreign Private Issuer
8:15am
6-K
hvyf2g pzcr1y0g
15 Mar 22
Kamada Issues 2022 CEO Letter to Shareholders
7:11am
6-K
qr8ws7i
15 Mar 22
Report of Foreign Private Issuer
7:08am
6-K
8l98wf
15 Mar 22
Provides Revenue and Profitability Guidance with Significant Growth Expected in 2022
7:02am
6-K
2js5p0lkxm78d25oh4nl
14 Mar 22
Kamada Expands U.S. Leadership Team with Two Key Appointments
7:01am
6-K
fhjbwnd9tj
3 Mar 22
Report of Foreign Private Issuer
7:41am